1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

Phase 2/3 Completed 80 enrolled Government Dental College and Research Institute, Bangalore

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the present study was to evaluate the effects of subgingival delivery of 1.2% Rosuvastatin (RSV) gel as an adjunct to scaling and root planing in chronic periodontitis (CP) with Type 2 diabetes mellitus patients.

Timeline

Start: 2015-11
Primary completion: 2016-07
Completion: 2016-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Rosuvastatin	Small molecule	1.2 %	Subcutaneous

1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus

Summary

Timeline

Drugs

Indications